Riociguat (BAY 63-2521) 50mg 50mg | Purity Not Available
Adooq Bioscience
Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageSotrastaurin is a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
More Information Supplier PageSotrastaurin is a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.
More Information Supplier PageSU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), KIT, and fms-like tyrosine kinase 3 (FLT-3)
More Information Supplier PageSU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), KIT, and fms-like tyrosine kinase 3 (FLT-3)
More Information Supplier PageSU14813 is an oral, multitargeted tyrosine kinase inhibitor (TKI) targeting vascular endothelial growth factor receptors (VEGFR), platelet-derived growth factor receptors (PDGFR), KIT, and fms-like tyrosine kinase 3 (FLT-3)
More Information Supplier PageSCH527123 is a potent and selective antagonist of the human CXCR1 and CXCR2 receptors with IC50 of 42 nM and 3 nM, respectively.
More Information Supplier PageSCH527123 is a potent and selective antagonist of the human CXCR1 and CXCR2 receptors with IC50 of 42 nM and 3 nM, respectively.
More Information Supplier Page